Apollo Eximss

Cabotres (Cabozantinib) tablets are an anticancer drug used for advanced kidney (renal cell), liver (hepatocellular), and thyroid cancers, working by blocking enzymes (tyrosine kinases) that promote cancer growth and blood supply to tumors, and are taken orally on an empty stomach, whole, daily, and require strict medical supervision due to potent side effects like high blood pressure, fatigue, and gastrointestinal issues. 

Cabotres (Cabozantinib) tablets are an anticancer drug used for advanced kidney (renal cell), liver (hepatocellular), and thyroid cancers, working by blocking enzymes (tyrosine kinases) that promote cancer growth and blood supply to tumors, and are taken orally on an empty stomach, whole, daily, and require strict medical supervision due to potent side effects like high blood pressure, fatigue, and gastrointestinal issues. 

Cazanat 20mg tablet is an antineoplastic drug with an active ingredient called Cabozantinib. It belongs to the medication class known as tyrosine kinase inhibitors. In adults, it is used to treat advanced kidney cancer and locally advanced or metastatic differentiated thyroid cancer. It is also used in treating liver cancer when Sorafenib (anticancer medicine) is no longer working. Usually, this medicine is given in combination with Nivolumab for advanced kidney cancer. It is not recommended for those younger than 18 years.   

 

 

Cazanat 40mg tablet is an antineoplastic drug with an active ingredient called Cabozantinib. It belongs to the medication class known as tyrosine kinase inhibitors. In adults, it is used to treat advanced kidney cancer and locally advanced or metastatic differentiated thyroid cancer. It is also used in treating liver cancer when Sorafenib (anticancer medicine) is no longer working. Usually, this medicine is given in combination with Nivolumab for advanced kidney cancer. It is not recommended for those younger than 18 years.   

 

 

Cazanat 60mg tablet is an antineoplastic drug with an active ingredient called Cabozantinib. It belongs to the medication class known as tyrosine kinase inhibitors. In adults, it is used to treat advanced kidney cancer and locally advanced or metastatic differentiated thyroid cancer. It is also used in treating liver cancer when Sorafenib (anticancer medicine) is no longer working. Usually, this medicine is given in combination with Nivolumab for advanced kidney cancer. It is not recommended for those younger than 18 years.